Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: A prospective analysis and comparison of two agents
- 31 December 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (6) , 855-860
- https://doi.org/10.1016/s0272-6386(96)90385-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Efficacy of oral iron therapy in patients receiving recombinant human erythropoietinAmerican Journal of Kidney Diseases, 1995
- Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for designStatistics in Medicine, 1992
- RACTICAL GUIDELINES FOR DRUG THERAPY IN DIALYSIS George R. Aronoff, Series Editor: Iron Dextran in Chronic Renal FailureSeminars in Dialysis, 1991
- Iron status in patients receiving erythropoietin for dialysis-associated anemiaKidney International, 1989
- Estimates of iron sufficiency in the US populationBlood, 1986
- Changes in Serum Ferritin Levels after Intravenous IronAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1981
- Metabolism of 59Fe-Dextran Complex in Human SubjectsBMJ, 1957